<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>17</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1215</FirstPage>
			<LastPage>1219</LastPage>
			<ELocationID EIdType="pii">32223</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Prasant </FirstName>
					<LastName>Yadav</LastName>
<Affiliation>Department of Biochemistry, Maulana Azad Medical College and Associated Hospitals, New Delhi, India</Affiliation>
<Identifier Source="ORCID">0000-0002-6061-5328</Identifier>

</Author>
<Author>
					<FirstName>Rashid </FirstName>
					<LastName>Mir</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Kajal </FirstName>
					<LastName>Nandi</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Jamsheed </FirstName>
					<LastName>Javid</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Mirza </FirstName>
					<LastName>Masroor</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Imtiyaz </FirstName>
					<LastName>Ahmad</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Mariyam </FirstName>
					<LastName>Zuberi</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>RCM </FirstName>
					<LastName>Kaza</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>SK </FirstName>
					<LastName>Jain</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Nita </FirstName>
					<LastName>Khurana</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Prakash Chandra</FirstName>
					<LastName>Ray</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Alpana </FirstName>
					<LastName>Saxena</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Background: Worldwide, breast cancer is the most common cancer among women and is a leading cause of cancer death. In the present study, we investigated the NQO1 C609T genotypic and allelic distribution in north Indian breast cancer patients. Materials and Methods: The genotypic distribution of the NQ01 C609T polymorphism was assessed in 100 invasive ductal carcinoma (IDC) breast cancer patients and 100 healthy controls using allele specific PCR (AS-PCR). Results: A lower frequency of the CC genotype was found in breast cancer patients (24%) than in the controls. On the other hand, TT genotype frequency was also found to be higher in female healthy controls (32%) than the female breast cancer patients (20%). The frequencies of all three genotypes CC, CT, TT in patients were 24%, 56% and 20% and in healthy controls 50%, 22% and 32% respectively. We did not find any significant correlation between the NQO1 C609T polymorphism and age group, grading, menopausal status and distant metastasis. A less significant association was found between the NQ01 C609T polymorphism and the stage of breast cancer (X2=5.931, P=0.05). Conclusions: The present study shows a strong association between NQO1 C609T polymorphism with the breast cancer risk in the north Indian breast cancer patients so that possible use as a risk factor should be further explored.</Abstract>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_32223_89d3efcc41f5b45d0bc8c73284bdc73c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
